Peer Reviewed Literature on Psilocybin

Since 2011 interest in psilocybin by accredited institutions has steadily progressed. Studies already conducted at John Hopkins University, The Multidisciplinary Association for Psychedelic Studies (MAPS), The Beckley Foundation, and New York University have shown promise for the safety and efficacy of psilocybin in treating a host of psychological conditions. Some of these conditions include depression, addiction, anxiety, OCD, PTSD, and eating disorders. Additional studies are currently underway at a variety of Ivy League Universities, including but not limited to Harvard, Stanford, Yale, The University of Toronto, and many more. 

Some of the Universities currently studying Psilocybin.

Some of the claims made regarding psilocybin and its capability to treat a variety of conditions on a long term basis, with low frequency of dosage, may seem exaggerated or outlandish. However they are backed by a body of scientifically meticulous research that is constantly expanding. We have curated a collection of relevant studies below.